🚀 VC round data is live in beta, check it out!
MediClin Valuation Multiples
Discover revenue and EBITDA valuation multiples for MediClin and similar public comparables like Goodwill Pharma, Athens Medical Centre, AirSculpt, Monash IVF Group and more.
MediClin Overview
About MediClin
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
Founded
1996
HQ
Employees
9.8K
Website
Sectors
Financials (LTM)
EV
$569M
MediClin Financials
MediClin reported last 12-month revenue of $923M and EBITDA of $131M.
In the same LTM period, MediClin generated $131M in EBITDA and $34M in net income.
Revenue (LTM)
MediClin P&L
In the most recent fiscal year, MediClin reported revenue of $882M and EBITDA of $125M.
MediClin expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $923M | XXX | $882M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $734M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 83% | XXX | XXX | XXX |
| EBITDA | $131M | XXX | $125M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $34M | XXX | $29M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MediClin Stock Performance
MediClin has current market cap of $193M, and enterprise value of $569M.
Market Cap Evolution
MediClin's stock price is $4.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $569M | $193M | -0.2% | XXX | XXX | XXX | $0.62 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMediClin Valuation Multiples
MediClin trades at 0.6x EV/Revenue multiple, and 4.4x EV/EBITDA.
EV / Revenue (LTM)
MediClin Financial Valuation Multiples
As of April 18, 2026, MediClin has market cap of $193M and EV of $569M.
Equity research analysts estimate MediClin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MediClin has a P/E ratio of 5.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $193M | XXX | $193M | XXX | XXX | XXX |
| EV (current) | $569M | XXX | $569M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 4.4x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBIT | 8.5x | XXX | 9.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.8x | XXX | XXX | XXX |
| P/E | 5.7x | XXX | 6.6x | XXX | XXX | XXX |
| EV/FCF | 7.8x | XXX | 13.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MediClin Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MediClin Margins & Growth Rates
MediClin's revenue in the last 12 month grew by 6%.
MediClin's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
MediClin's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MediClin's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
MediClin Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 76% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MediClin Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MediClin | XXX | XXX | XXX | XXX | XXX | XXX |
| Goodwill Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| AirSculpt | XXX | XXX | XXX | XXX | XXX | XXX |
| Monash IVF Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Limes Schlosskliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MediClin M&A Activity
MediClin acquired XXX companies to date.
Last acquisition by MediClin was on XXXXXXXX, XXXXX. MediClin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MediClin
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMediClin Investment Activity
MediClin invested in XXX companies to date.
MediClin made its latest investment on XXXXXXXX, XXXXX. MediClin invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MediClin
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MediClin
| When was MediClin founded? | MediClin was founded in 1996. |
| Where is MediClin headquartered? | MediClin is headquartered in Germany. |
| How many employees does MediClin have? | As of today, MediClin has over 9K employees. |
| Is MediClin publicly listed? | Yes, MediClin is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of MediClin? | MediClin trades under MED ticker. |
| When did MediClin go public? | MediClin went public in 2000. |
| Who are competitors of MediClin? | MediClin main competitors are Goodwill Pharma, Athens Medical Centre, AirSculpt, Monash IVF Group. |
| What is the current market cap of MediClin? | MediClin's current market cap is $193M. |
| What is the current revenue of MediClin? | MediClin's last 12 months revenue is $923M. |
| What is the current revenue growth of MediClin? | MediClin revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of MediClin? | Current revenue multiple of MediClin is 0.6x. |
| Is MediClin profitable? | Yes, MediClin is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MediClin? | MediClin's last 12 months EBITDA is $131M. |
| What is MediClin's EBITDA margin? | MediClin's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of MediClin? | Current EBITDA multiple of MediClin is 4.4x. |
| What is the current FCF of MediClin? | MediClin's last 12 months FCF is $73M. |
| What is MediClin's FCF margin? | MediClin's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of MediClin? | Current FCF multiple of MediClin is 7.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.